John Loike is an American research biologist and bioethicist in Columbia University.
Biography
Loike has a Ph.D from the Albert Einstein College of Medicine of Yeshiva University. His research focuses on the role of inflammation in cancer and neurodegenerative diseases. He has published many articles in leading scientific journals including Science, Nature, Journal of Experimental Medicine, Journal of Cell Biology, New England Journal of Medicine, Lancet, PNAS, PlosOne, Journal of Biological Chemistry and The Scientist. In addition he has authored or co-authored several books. He is the Director for Special Programs for the Center for Bioethics in Columbia University and is a faculty member of the Department of Physiology and Cellular Biophysics at Columbia University College of Physicians and Surgeons. He teaches two undergraduate courses and one graduate course. He is also the creator and faculty editor of the "Columbia University 'Journal of Bioethics.'' Dr. Loike has published many ground-breaking articles on bioethics and specifically deals with bioethics from a Jewish perspective, for which he often teams with Rabbi Dr. Moshe David Tendler. His articles have dealt with such issues as stem cells, cloning, neuroethics, bioterrorism, and the interface of science and religion. Many of these issues are hotly debated around the world, and specifically in Israel, where religious leaders have a big influence in public policy. Dr. Loike has weighed in on these issues in Israeli forums, leading to policy changes there. Serving on a Rabbinical Council of America panel on stem cell research, Dr. Loike highlighted scientific innovations that could allow for additional research, while alleviating the ethical questions posed by the scientific use of embryonic stem cells.
In 1982, Loike and his longtime study partner, David Hurwitz, published a first-of-its-kind guide to Passover medications. Up until that point, no one had produced a scientific study of leaven ingredients in medications and as a result, many religious Jews had to decide on their own whether their medication could be consumed during Passover according to Jewish Law. Loike and Hurwitz painstakingly contacted various drug manufacturers to ascertain the status of their various medications. This led to a yearly publication of passover medications.
Books
Lignans: Chemical, Biological and Clinical Properties by David C. Ayres and John D. Loike. Cambridge University Press, 2008.
'"Frontiers in Bioethics" by John D. Loike and Ruth L. Fischbach, 2012;
'"'Science-based Bioethics", by John D. Loike and Ruth L. Fischbach, 2014.
'"'Science-based Bioethics", by John D. Loike and Ruth L. Fischbach, 2016.
Selected Articles
Loike, J.D. The Evolving Bioethical Landscape of Human-Animal Chimeras, in "Human Dignity in Bioethics: From Worldviews to the Public Square.". 2013.
Loike, J.D., Rush, B.S., Schweber, A., Fischbach, R. L. Lessons Learned from Undergraduate Students in Designing a Science-based Course in Bioethics, Cell Biology Education—A Journal of Life Science Education, December, 2013.
Loike, J.D. and Miller, J. Personalized Medicine, Encyclopedia of Bioethics, In Press 2013.
Loike, J.D. Tendler, M.D. Halachic Perspectives of Gestational Surrogacy, Hakirah, In Press, 2013.
Margolit, Y., Levy, O., Loike, J.D., Advanced Reproductive Technologies: Reevaluating Modern Parentage, Harvard Journal of Law and Gender, in press 2013.
Loike, J.D., Hirano, M., Margalit, H., Three-Way Parenthood: dealing with the logistics of embryos created by three-parent IVF technologies that avoid the transmission of mitochondrial disease. Oct 1, The Scientist, 2013.
Loike, J.D. The Power to Predict: Using DNA Technologies to Assess the Genetics and Health of a Fetus. B’Or Ha’Torah. Jan, 2012.
Loike, J.D. DNA Technology: The power to detect and create. The Jewish Press pg 18, July 2, 2010.
Loike, J.D. and Tendler, M.D. Ethical Dilemmas in Stem Cell Research: Human-Animal Chimeras. Tradition, 40:20-50, 2007.
Li, Y., Karlin, A., Loike, J.D., and Silverstein, S.C. 2004. Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J Exp Med. 200:613-22.
